Cerevel Therapeutics Holdings Inc (DELISTED) (CERE:DL)
44.97
USD |
NASDAQ |
Jul 31, 16:00
Cerevel Therapeutics Holdings Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AbbVie, Inc. | -10.95 |
| Amgen, Inc. | 6.238 |
| Biogen, Inc. | 0.3518 |
| Gilead Sciences, Inc. | 0.943 |
| Eli Lilly & Co. | 1.390 |